|
Other Treatment
Citations 261-270 of 722 total displayed.
|
Past content
(since Jan 1999):
|
- Basic Science for Clinicians
Tissue Factor in Cardiovascular Diseases: Molecular Mechanisms and Clinical Implications
- Jan Steffel, Thomas F. Lüscher, and Felix C. Tanner
Circulation 2006;113:722-731, doi:10.1161/CIRCULATIONAHA.105.567297
[Abstract]
[Full text]
- Correspondence
Letter Regarding Article by Tonelli et al, "Effect of Pravastatin on Rate of Kidney Function Loss in People With or at Risk for Coronary Disease" • Response
- Arash Rashidi, Mahboob Rahman, Marcello Tonelli, Chris Isles, Timothy Craven, Curt Furberg, Andrew Tonkin, Marc A. Pfeffer, James Shepherd, Stuart M. Cobbe, Frank M. Sacks, John Simes, Malcolm West, Chris Packard, and Gary C. Curhan
Circulation 2006;113:e59-60e, doi:10.1161/CIRCULATIONAHA.105.576926
[Full text]
- Health Services and Outcomes Research
Proliferation of Cardiac Technology in Canada: A Challenge to the Sustainability of Medicare
- David A. Alter, Therese A. Stukel, and Alice Newman
Circulation 2006;113:380-387, doi:10.1161/CIRCULATIONAHA.105.560466
[Abstract]
[Full text]
- Editorials
Evidence-Based Medicine: Making the Grade: Miles to Go Before We Sleep
- Sidney C. Smith, Jr
Circulation 2006;113:178-179, doi:10.1161/CIRCULATIONAHA.105.592238
[Full text]
- Editorials
Revascularization in Systolic Heart Failure: A Difficult Decision
- Raymond J. Gibbons, Panithaya Chareonthaitawee, and Kent R. Bailey
Circulation 2006;113:180-182, doi:10.1161/CIRCULATIONAHA.105.595462
[Full text]
- Health Services and Outcomes Research
Antihypertensive Medication Use Among US Adults With Hypertension
- Qiuping Gu, Ryne Paulose-Ram, Charles Dillon, and Vicki Burt
Circulation 2006;113:213-221; published online before print as doi:10.1161/CIRCULATIONAHA.105.542290
[Abstract]
[Full text]
- Articles
Antihypertensive Medication Use Among US Adults With Hypertension
- Qiuping Gu, Ryne Paulose-Ram, Charles Dillon, and Vicki Burt
Circulation published January 3, 2006, doi:10.1161/CIRCULATIONAHA.105.542290
[Abstract]
- Heart Failure
Cost-Effectiveness of Fixed-Dose Combination of Isosorbide Dinitrate and Hydralazine Therapy for Blacks With Heart Failure
- Derek C. Angus, Walter T. Linde-Zwirble, S. William Tam, Jalal K. Ghali, Michael L. Sabolinski, Victor G. Villagra, Wolfgang C. Winkelmayer, Manuel Worcel for the African-American Heart Failure Trial (A-HeFT) Investigators
Circulation 2005;112:3745-3753, doi:10.1161/CIRCULATIONAHA.105.563882
[Abstract]
[Full text]
- Heart Failure
Integrated Hemodynamic, Hormonal, and Renal Actions of Urocortin 2 in Normal and Paced Sheep: Beneficial Effects in Heart Failure
- Miriam T. Rademaker, Vicky A. Cameron, Christopher J. Charles, and A. Mark Richards
Circulation 2005;112:3624-3632, doi:10.1161/CIRCULATIONAHA.105.561308
[Abstract]
[Full text]
- Controversies in Cardiovascular Medicine
Importance of Race/Ethnicity in Clinical Trials: Lessons From the African-American Heart Failure Trial (A-HeFT), the African-American Study of Kidney Disease and Hypertension (AASK), and the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
- Anne L. Taylor, Jackson T. Wright, Jr, Richard S. Cooper, Bruce M. Psaty, Anne L. Taylor, Jackson T. Wright, Jr, Richard S. Cooper, and Bruce M. Psaty
Circulation 2005;112:3654-3666, doi:10.1161/CIRCULATIONAHA.105.540443
[Full text]
|
|
